Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Atreca, Inc. | 50,431 | reported | 01 Sept 2023 | tx 18+749,666−299,235 |
| Maze Therapeutics, Inc. | 32,000 | reported | 02 Mar 2026 | tx 3+70,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 02 Mar 2026 | GRANT_AWARD | Maze Therapeutics, Inc. | 16,000 | 0.00 USD | deriv |
| 02 Mar 2026 | GRANT_AWARD | Maze Therapeutics, Inc. | 32,000 | 0.00 USD | deriv |
| 22 Sept 2025 | GRANT_AWARD | Maze Therapeutics, Inc. | 22,000 | 0.00 USD | deriv |
| 01 Sept 2023 | SALE | Atreca, Inc. | 7,061 | 0.37 USD | |
| 02 Aug 2023 | SALE | Atreca, Inc. | 4,076 | 0.95 USD | |
| 09 Feb 2023 | GRANT_AWARD | Atreca, Inc. | 32,500 | 0.00 USD | |
| 09 Feb 2023 | GRANT_AWARD | Atreca, Inc. | 130,000 | 0.00 USD | deriv |
| 02 Sept 2022 | SALE | Atreca, Inc. | 6,432 | 1.78 USD | |
| 13 Jun 2022 | OTHER | Atreca, Inc. | 65,000 | 0.00 USD | deriv |
| 13 Jun 2022 | GRANT_AWARD | Atreca, Inc. | 80,000 | — | deriv |
| 13 Jun 2022 | OTHER | Atreca, Inc. | 80,000 | 0.00 USD | deriv |
| 13 Jun 2022 | GRANT_AWARD | Atreca, Inc. | 45,000 | — | deriv |
| 13 Jun 2022 | OTHER | Atreca, Inc. | 45,000 | 0.00 USD | deriv |
| 13 Jun 2022 | GRANT_AWARD | Atreca, Inc. | 91,666 | — | deriv |
| 13 Jun 2022 | OTHER | Atreca, Inc. | 91,666 | 0.00 USD | deriv |
| 13 Jun 2022 | GRANT_AWARD | Atreca, Inc. | 65,000 | — | deriv |
| 23 Dec 2021 | GRANT_AWARD | Atreca, Inc. | 80,000 | 0.00 USD | deriv |
| 09 Sept 2021 | GRANT_AWARD | Atreca, Inc. | 35,500 | 0.00 USD | |
| 27 Jan 2021 | GRANT_AWARD | Atreca, Inc. | 80,000 | 0.00 USD | deriv |
| 26 Feb 2020 | GRANT_AWARD | Atreca, Inc. | 65,000 | 0.00 USD | deriv |
| 11 Jul 2019 | GRANT_AWARD | Atreca, Inc. | 45,000 | 0.00 USD | deriv |